Singapore’s Health Care System: Cost, Access, Outcomes, and What the United States Can (and Can’t) Learn
The model everyone admires — and reads selectively
- What: Singapore covers everyone, lives longer than almost anyone, and spends about a quarter of what the US spends — through an unusual mix of forced savings, catastrophic insurance, subsidies, and heavy government control.
- The numbers: Singapore spends ~5% of GDP on health; the US spends ~17.6%. Life expectancy is 83.5 years vs. 79.0 in the US (2024). 100% of Singaporeans have public coverage.
- The shadow: roughly a third of Singapore’s population are migrant workers, who are excluded from government subsidies. COVID-19 exposed this sharply.
- Why it matters: Singapore is the system US reformers on the left and right both point to. This case asks whether the US can learn from it — and whether its success can be separated from the trade-offs that produce it.
- Pair with: Why US Health Care Costs So Much
The Case
Every American who studies health policy eventually runs into Singapore, and has the same reaction: how?
The United States spends close to 18% of its entire economy on health care — about $14,900 per person (2024) — and gets middling results. Singapore spends roughly 5% of GDP, a quarter of the US share. Yet Singaporeans live to 83.5 on average, about four and a half years longer than Americans, and everyone is covered (The Commonwealth Fund 2026). On paper, Singapore looks like it solved the puzzle the US can’t.
It did not do so by building a British-style national health service, or a Canadian single-payer plan, or a German system of insurance funds. It built something stranger.
The “S+3Ms” framework. Singapore funds health care through four layers (The Commonwealth Fund 2026).
- Subsidies: the government pays up to 80% of the bill in public hospital wards, with the biggest subsidies for those who choose the most basic accommodations.
- MediSave (1984): a compulsory savings account. Workers must set aside 8–10.5% of every paycheck in a personal medical account they can later spend on care.
- MediShield Life (2015): mandatory national insurance for catastrophic bills — big hospital stays and costly treatments. Everyone is in it, including people with pre-existing conditions.
- MediFund: a government endowment that catches those who still can’t pay after the other three layers.
The design has a philosophy. Singapore wants you to feel the cost of routine care, so you spend your own MediSave dollars on small things. It pools money only for the big, unpredictable bills that would bankrupt a family. And it keeps a safety net under everyone who falls through.
This system was not built in one stroke. It grew piece by piece over forty years — MediSave in 1984, MediShield in 1990, MediFund in 1993, and finally MediShield Life in 2015, which closed the gaps by making coverage truly universal and lifelong. Each step added a layer rather than replacing the system, much as the US did. The difference is that Singapore was building toward a plan, while the US was patching an accident.
The money still comes from a mix of sources. In 2022 the government paid about 57% of all health spending, and individuals paid roughly a quarter out of pocket — a higher share than in most rich countries (The Commonwealth Fund 2026). Singapore is comfortable making patients pay at the point of care, on the theory that a price you can feel is a price you think about. Whether that restraint is wise or harsh is part of what the case is about.
The system also nudges behavior in ways Americans would find startling. Public hospital wards are tiered: a “C” ward holds many beds in one room and is heavily subsidized; an “A” ward is a private room with little or no subsidy. You can have comfort, or you can have a big subsidy, but not both. The choice quietly sorts people by what they’re willing to pay for — a form of rationing that patients impose on themselves.
The part that’s easy to miss. Behind the savings accounts sits a powerful government hand. Singapore’s state owns most of the acute hospitals, controls how many are built, and negotiates or sets the prices of drugs and procedures. This is supply-side control — managing the cost and amount of care from the top, not just the demand for it. Much of Singapore’s low spending comes from this control, not from the savings accounts alone (Haseltine 2013).
Then came the test no one plans for.
When COVID-19 arrived, Singapore looked like a global model. It moved early and hard. National apps — TraceTogether and SafeEntry — let officials trace contacts within hours. When community spread grew, the country imposed a “circuit breaker” lockdown. Later it ran one of the world’s most successful vaccination drives, reaching more than 96% of eligible people. Its case-fatality rate settled at about 0.08% — among the very lowest on Earth.
But the worst outbreak did not happen among citizens. It tore through the dormitories of migrant workers — the men who build Singapore’s towers and clean its streets. Hundreds of thousands of them live packed into shared rooms, often a dozen or more to a unit. The virus moved through that crowding fast. At the peak, well over 47% of dormitory workers had been infected, and for months they made up the overwhelming majority of Singapore’s cases (Koh 2020).
Very few of these workers died — most are young men, so the dormitory outbreak was enormous in cases but small in deaths. Yet they had been living in conditions that made an outbreak almost certain, in a country famous for control and order. These workers are about a third of Singapore’s population, and they are not eligible for the government subsidies that protect citizens.
So Singapore’s celebrated COVID numbers told a true story and hid one at the same time. The country protected its citizens superbly. It had also built a second, lower track for the people it depended on most — and the pandemic shoved that track into view. The low national death rate was partly a fact about Singapore’s system, and partly a fact about who was counted as fully inside it.
The Argument Singapore Started
Singapore is not really one argument. It is a screen onto which people project the system they already wanted. The exchange below tries to separate what Singapore actually does from what its admirers wish it did.
The case for copying it
Start with the appeal, because it is real and bipartisan.
The Emulation Argument
- A just and efficient health system should deliver good health outcomes for everyone at a sustainable cost.
- Singapore delivers near-top outcomes, universal coverage, and long lives at about a quarter of the US cost.
- Therefore, the US should adopt the key features of Singapore’s system.
What makes this argument unusual is who makes it. American conservatives love MediSave: people spend their own money, feel the cost, and avoid waste — personal responsibility built into the system. It is the dream behind US health savings accounts. American progressives love that coverage is universal, that the government sets prices and owns the hospitals, and that no one goes bankrupt from a hospital bill. It is the dream behind a public system.
Both camps look at Singapore and see their own ideals confirmed. A system claimed as proof by people who agree on nothing is usually doing something more complicated than either story admits — and each side is describing only the part that flatters its own view.
Which model is it?
The four classic models. Most countries build their system on one of four templates (Reid 2009).
- Beveridge: the government owns the hospitals and pays for care from taxes (the UK’s NHS).
- National Health Insurance: care is delivered privately, but a single government insurer pays the bills (Canada).
- Bismarck: private providers and private nonprofit insurance “funds,” tightly regulated so everyone is covered (Germany).
- Out-of-pocket: there is no system; you pay for what you can afford (much of the developing world).
Singapore fits none of them cleanly.
- Its forced savings accounts look like a regulated version of out-of-pocket — you pay, but from a mandated account.
- Its catastrophic insurance (MediShield Life) looks like National Health Insurance for big bills.
- Its government-owned hospitals and price-setting look like Beveridge.
It is, in effect, a fifth model — a deliberate hybrid. In the US debate, each faction grabs the one piece that resembles its preferred model and ignores the rest. The conservative sees the out-of-pocket gear; the progressive sees the Beveridge gear. Singapore only works because it bolts them together.
The shadow: who’s left out
Now the hardest move, and the moral heart of the case.
A defender says: Singapore proves you can cover everyone well and cheaply. But “everyone” hides a choice. Singapore’s superb averages rest partly on a population it does not fully include — the migrant workers who are barred from subsidies and were left in crowded dormitories when the virus came.
Why this is a justice problem, not just a footnote. Philosophers who study health justice argue that a society’s duties run to all the people whose labor sustains it, and that health is shaped by social determinants — housing, work, and income, not just clinics (MacKay and Sreenivasan 2021). On a Rawlsian view, a system should be judged by how it treats its worst-off members. By that test, Singapore’s dormitory residents are exactly the people the numbers leave out.
The Exclusion Argument
- A health system should be judged by how it treats its worst-off members, not only by its averages.
- Singapore achieves part of its low cost and high averages by excluding migrant workers — about a third of its population — from full coverage.
- Excellent averages bought partly through exclusion do not show that a system is just.
- Therefore, Singapore’s headline success cannot be read, on its own, as a model of justice for others to copy.
Singapore’s achievement is real; the exclusion changes what it shows. The efficiency Americans admire may not be separable from it — tidy national numbers and a hidden second track may simply come together.
The US is in no position to feel superior. It has its own excluded groups: undocumented immigrants who get only emergency care, and the millions who fall into the coverage gap between Medicaid and the exchanges. Every health system draws a line around who fully counts. Singapore’s line is just unusually visible — drawn between citizens and the workers who build the city. The US draws lines too, and its own are not obviously easier to defend.
Can it transfer?
Suppose the US wanted to learn the real lessons anyway. Could it?
Several features that make Singapore work may not cross the ocean.
- Scale. Singapore is a wealthy city-state of under six million. The US is a continent of 340 million, with fifty states and no single health authority.
- Governance. Singapore is run by one dominant party that can impose forced savings, set prices, and track citizens with little pushback. US politics blocks far smaller moves.
- Culture. Singapore’s system assumes a level of trust in government, and acceptance of paternalism, that the US does not share.
- Membership. Singapore’s model depends on a sharp line between citizens, who are protected, and non-citizens, who are not. The US draws lines too, but a model built on that exclusion sits badly with its stated ideals.
Some pieces might still travel. The US could borrow Singapore’s supply-side price control — public price-setting and bulk drug purchasing — without forcing anyone to open a savings account. It could add catastrophic-only public insurance, so that no illness bankrupts a family, while leaving routine care to the market. It could fund a real safety net like MediFund for those who exhaust everything else.
But notice that each of these “lessons” is really a value choice dressed as a technical fix. Price control means deciding that the government, not the market, sets what care is worth. Catastrophic-only insurance means deciding that people should feel the cost of routine care — a stance that looks like prudence to one person and cruelty to another. Singapore did not stumble into these answers. It chose them, and accepted the trade-offs. The US cannot borrow the answers without making the same choices.
What Singapore really offers the US is not a blueprint. It is a mirror. Each side sees the system it wanted and calls it proof. The honest lesson may be the uncomfortable one: that Singapore’s enviable numbers come bundled with state control and a two-track membership most Americans say they would refuse — and that you cannot reliably buy the outcomes without buying the trade-offs.
Discussion Questions
- Both American conservatives and progressives cite Singapore as proof of their own approach. What does that tell you about using a single foreign country as evidence in a policy debate? How should you reason about “what works elsewhere”?
- Singapore’s low costs come largely from government control of hospitals and prices, not from patient savings accounts. If the US adopted MediSave-style accounts without price control, what would you predict — and why?
- Is excluding migrant workers from subsidies a flaw in Singapore’s system, or a feature that helps produce its low costs and good averages? Can a system be both highly efficient and unjust?
- Singapore’s model depends on a paternalistic government, forced savings, and national health tracking. Are these acceptable prices for universal, low-cost care? Defend your line using a theory of justice.
- Pick one element of Singapore’s system you think the US should adopt and one it should not. For each, name the value (from Part A) that drives your choice.